Laurie Toich, Assistant Editor

Midostaurin (Rydapt) approved to treat acute FLT3 mutation positive acute myeloid leukemia.

Top news of the day from across the healthcare landscape.

C-THRU Act seeks to improve transparency among pharmacy benefit managers.

Glecaprevir/pibrentasvir combination shows promise as a novel hepatitis C virus treatment.

Numerous opportunities for networking exist at the annual Asembia Specialty Pharmacy Summit.

Proposed rule aims to increase transparency, flexibility, and innovation in care delivery.

A reduction in the release of serotonin and dopamine may cause chemotherapy-related cognitive decline.

Cognitive decline in patients with cancer administered chemotherapy may be a result of increased levels of hydrogen peroxide in the brain.

New biomarkers could accurately predict the risk of renal failure among patients with type 1 and type 2 diabetes.

Mitochondrial circuit prevents widespread damage to heart muscle.

Top news of the day from across the healthcare landscape.

Pharmacists gather on capitol hill to garner Congressional support for pharmacy- and patient-focused legislation.

A large portion of patients may be paying for drugs based on list prices.​

Cannabinoids observed to reduce inflammation in various skin conditions.

Medicare beneficiaries with chronic venous insufficiency nearly triples from 2005 to 2014.

Moderate or high physical activity improved heart attack survival by 47%.

Top news of the day from across the healthcare landscape.

Various health reform approaches may affect each pharmaceutical manufacturer differently.

Pharmacists and pharmacies have become key players in improving patient outcomes.

FDA takes action against 65 products that claim to prevent, diagnose, treat, or cure cancer.

Mislabeled phenobarbital tablets may result in overdose, the FDA warns.

Experimental drug may be able to treat spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.

The AHA Precision Medicine Platform is expected to greatly improve cardiovascular care.

Study finds drug prices have been both increasing and decreasing for prescription drugs, independent of rebates.

Top news of the day from across the healthcare landscape.

Drug list prices may not increase because of rebates negotiated by pharmacy benefit managers.

Proposed legislation would increase PBM transparency regarding drug costs.

High-dose vitamin D not found to reduce cardiovascular disease or death.

Type 2 diabetes cases increased 8.5% per year among some populations.

Top news of the day from across the healthcare landscape.